Login
$EXEL
$66.31 +$0.96 (1.47%) Live

Company Executives

Officer Age In this role Joined 2025 pay Source
Michael M. Morrissey Also a director
President and Chief Executive Officer
65 Not stated Not stated $33,239,183
Christopher J. Senner
Executive Vice President and Chief Financial Officer
58 Since 2015
11 years
Not stated $10,648,472
Brenda J. Hefti
Senior Vice President and General Counsel
52 Since 2025
1 year
Not stated $4,204,271
Dana T. Aftab
Executive Vice President, Research and Development
63 Not stated Not stated $10,547,248
Patrick J. Haley
Executive Vice President, Commercial
50 Since 2020
6 years
Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
11
serving now
Independent
Not stated
the proxy does not say
Average tenure
11.2 years
from year joined
CEO also chairs the board
No
Stelios Papadopoulos
Director Age On board Independent Committees Other public boards 2025 pay Source
Stelios Papadopoulos
77 1994
32 years
Not stated None stated Ovid Therapeutics Inc. Not stated
Michael M. Morrissey
65 2010
16 years
Not stated None stated Vera Therapeutics, Inc. Paid as CEO
Mary C. Beckerle
71 2024
2 years
Not stated None stated Huntsman Corporation, Johnson & Johnson Not stated
S. Gail Eckhardt
68 2024
2 years
Not stated None stated None stated $504,491
Maria C. Freire
71 2018
8 years
Not stated None stated Alexandria Real Estate Equities, Biogen Inc. Not stated
Tomas J. Heyman
70 2023
3 years
Not stated
Governance Committee Risk Committee · Chair
Legend Biotech Corporation $517,491
David E. Johnson
43 2023
3 years
Not stated
Audit Committee Research & Development Committee
Liquidia Corporation $507,209
Robert (Bob) L. Oliver, Jr.
67 2023
3 years
Not stated None stated None stated $501,991
George Poste
81 2004
22 years
Not stated None stated Caris Life Sciences, Inc. Not stated
Julie Anne Smith
55 2016
10 years
Not stated
Audit Committee Compensation Committee · Chair
Stoke Therapeutics, Inc. $520,491
Jack L. Wyszomierski
70 2004
22 years
Not stated None stated XOMA Corporation, SiteOne Landscape Supply, Inc. $519,991

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

2 disclosed in the proxy filed Apr 15, 2026
BlackRock, Inc.
$481.8 million
As of January 2, 2026

BlackRock managed a portion of the company's cash and investments portfolio; fair value of managed cash and investments was $481.8 million as of January 2, 2026.

BlackRock, Inc.
$0.3 million

Fees paid for BlackRock advisory services performed during the year ended January 2, 2026.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support